In the Media
Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
Visit: Head of BioMed X Wins Business Worldwide Magazine’s CEO Award
Head of BioMed X Wins Business Worldwide Magazine’s CEO Award
Yahoo Finance
The Awards seek to identify and honour the most respected C-level executives across the globe, from a comprehensive range of sectors.
Visit: Head of BioMed X Wins Business Worldwide Magazine’s CEO Award
Head of BioMed X Wins Business Worldwide Magazine’s CEO Award
Pharmaboardroom.com
The Founder and Managing Director of German biotechnology company BioMed X has been named “Biotechnology CEO Of The Year- Europe” in the Business Worldwide Magazine (BWM) 2020 CEO Awards.
Visit: Head of BioMed X Wins Business Worldwide Magazine’s CEO Award
Head of BioMed X Wins Business Worldwide Magazine’s CEO Award
seekingalpha.com
The Awards seek to identify and honour the most respected C-level executives across the globe, from a comprehensive range of sectors.
Visit: Head of BioMed X Wins Business Worldwide Magazine’s CEO Award
Head of BioMed X Wins Business Worldwide Magazine’s CEO Award
marketwatch.com
The Founder and Managing Director of German biotechnology company BioMed X has been named “Biotechnology CEO Of The Year- Europe” in the Business Worldwide Magazine (BWM) 2020 CEO Awards.
Visit: Interview with Christian Tidona, CEO of BioMed X at the London Stock Exchange Studios
Interview with Christian Tidona, CEO of BioMed X at the London Stock Exchange Studios
Business Worldwide Magazine
BioMed X founder and Managing Director, Dr. Christian Tidona, interviewed on BioMed X’ s track record by Nadira Tudor of Business Worldwide Magazine.
Visit: Leveraging synergies in pre-clinical biomedical R&D – pharmaceutical companies benefit from new innovation models
Leveraging synergies in pre-clinical biomedical R&D – pharmaceutical companies benefit from new innovation models
Word Pharma Today
As the complexity of pharmaceutical research and development increases constantly, its innovation productivity defined as the successful approval and launch of truly novel drugs and therapies, has declined since years.